Cullgen rakes in $50m Series B

Cullgen Inc., a biotechnology company, has raised $50 million in Series B financing.

Cullgen Inc., a biotechnology company, has raised $50 million in Series B financing. The investors include 3E Bioventures Capital, Heights Capital Management, Octagon Capital, MSA Capital and South China Venture Capital.

Source: Press Release